Since COVID, the FDA has granted EUA to multiple (4+) monoclonal antibodies. In our experience, monoclonal antibodies have led to swift improvement in COVID symptoms, but since we have a new strain of COVID and a new form of monoclonal antibodies, we are looking for feedback from our patients to assess how well they are working.
Please take two minutes and complete our survey. Feel free to share to friends and family. We will post results soon.